TY - JOUR
T1 - Controlled ovulation of the dominant follicle
T2 - A critical role for LH in the late follicular phase of the menstrual cycle
AU - Young, Kelly A.
AU - Chaffin, Charles L.
AU - Molskness, Theodore A.
AU - Stouffer, Richard L.
PY - 2003/11
Y1 - 2003/11
N2 - Background: A method was sought to control ovulation of the dominant follicle and to test the importance of LH during the late follicular phase of the menstrual cycle. Menstrual cycles of rhesus monkeys were monitored, and treatment initiated at the late follicular phase (after dominant follicle selection, before ovulation). Methods: The 2-day treatment consisted of GnRH antagonist plus either r-hFSH and r-hLH (1:1 or 2:1 dose ratio) or r-hFSH alone. In addition, half of the females received an ovulatory bolus of hCG. Results: When treatment was initiated at estradiol levels >120 pg/ml, neither the endogenous LH surge, ovulation nor luteal function were controlled. However, when treatment was initiated at estradiol levels 80-120 pg/ml using either 1:1 or 2:1 dose ratios of FSH:LH, the LH surge was prevented, and ovulation occurred following hCG treatment. FSH-only treatment also prevented the LH surge, but follicle development appeared abnormal, and hCG failed to stimulate ovulation. Conclusions: Control over the naturally dominant follicle is possible during the late follicular phase using an abbreviated GnRH antagonist, FSH+LH protocol. This method offers a model to investigate periovulatory events and their regulation by gonadotrophins/local factors during the natural menstrual cycle in primates.
AB - Background: A method was sought to control ovulation of the dominant follicle and to test the importance of LH during the late follicular phase of the menstrual cycle. Menstrual cycles of rhesus monkeys were monitored, and treatment initiated at the late follicular phase (after dominant follicle selection, before ovulation). Methods: The 2-day treatment consisted of GnRH antagonist plus either r-hFSH and r-hLH (1:1 or 2:1 dose ratio) or r-hFSH alone. In addition, half of the females received an ovulatory bolus of hCG. Results: When treatment was initiated at estradiol levels >120 pg/ml, neither the endogenous LH surge, ovulation nor luteal function were controlled. However, when treatment was initiated at estradiol levels 80-120 pg/ml using either 1:1 or 2:1 dose ratios of FSH:LH, the LH surge was prevented, and ovulation occurred following hCG treatment. FSH-only treatment also prevented the LH surge, but follicle development appeared abnormal, and hCG failed to stimulate ovulation. Conclusions: Control over the naturally dominant follicle is possible during the late follicular phase using an abbreviated GnRH antagonist, FSH+LH protocol. This method offers a model to investigate periovulatory events and their regulation by gonadotrophins/local factors during the natural menstrual cycle in primates.
KW - Dominant follicle/GnRH antagonist
KW - Gonadotrophins
KW - LH
KW - Ovarian stimulation
UR - http://www.scopus.com/inward/record.url?scp=0242690946&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0242690946&partnerID=8YFLogxK
U2 - 10.1093/humrep/deg467
DO - 10.1093/humrep/deg467
M3 - Article
C2 - 14585870
AN - SCOPUS:0242690946
SN - 0268-1161
VL - 18
SP - 2257
EP - 2263
JO - Human Reproduction
JF - Human Reproduction
IS - 11
ER -